Celgene Corp - Strategic SWOT Analysis Review

December 2021 | 41 pages | ID: CB58C7E3CB3DEN
GlobalData

Abstracts

Celgene Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Celgene Corp (Celgene), a subsidiary of Bristol-Myers Squibb Co, is an integrated biopharmaceutical company that discovers, develops, manufactures, and markets novel gene and protein regulation therapies for the treatment of cancer and immune-inflammatory diseases. Its major product portfolio includes Revlimid (lenalidomide), Pomalyst (pomalidomide) and Thalomid (thalidomide) for the treatment of multiple myeloma; and Abraxane (paclitaxel albumin-bound particles for injectable suspension) for various types of cancers, among others. The company sells its products through own sales organizations and distributors in Europe, the Americas, the Middle-East and Asia-Pacific. Celgene is headquartered in Summit, New Jersey, the US.

Celgene Corp Key Recent Developments

Jun 18,2020: Recombinant antibody network partners with Bristol Myers Squibb to develop novel therapies
May 28,2020: GNS Healthcare and Collaborators identify PHF19 as marker of aggressive multiple myeloma
Mar 05,2020: Bristol Myers Squibb unveils new branding
Mar 04,2020: Pulmonary Fibrosis Foundation launches industry consortium to identify biomarkers in Pulmonary Fibrosis

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Celgene Corp - Key Facts
Celgene Corp - Key Employees
Celgene Corp - Major Products and Services
Celgene Corp - History
Celgene Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Celgene Corp - Business Description
Celgene Corp - Corporate Strategy
Celgene Corp - SWOT Analysis
SWOT Analysis - Overview
Celgene Corp - Strengths
Celgene Corp - Weaknesses
Celgene Corp - Opportunities
Celgene Corp - Threats
Celgene Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Celgene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Celgene Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Celgene Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jun 18, 2020: Recombinant antibody network partners with Bristol Myers Squibb to develop novel therapies
May 28, 2020: GNS Healthcare and Collaborators identify PHF19 as marker of aggressive multiple myeloma
Mar 05, 2020: Bristol Myers Squibb unveils new branding
Mar 04, 2020: Pulmonary Fibrosis Foundation launches industry consortium to identify biomarkers in Pulmonary Fibrosis

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Celgene Corp, Key Facts
Celgene Corp, Key Employees
Celgene Corp, Major Products and Services
Celgene Corp, History
Celgene Corp, Other Locations
Celgene Corp, Subsidiaries
Celgene Corp, Key Competitors
Celgene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Celgene Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Celgene Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Celgene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Celgene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021